|
|
|
|
Vol. 16, Issue 3, 1555-1567, March 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







* Department of Medicine and Biochemistry, Medical University of South Carolina, Charleston, SC 28425;
Department of Molecular Biology, Medical University of South Carolina, Charleston, SC 28425;
Division of Bioengineering and Physical Sciences, National Institutes of Health, Bethesda, MD 20892; and
Ralph H. Johnson Veterans Administration Hospital, Charleston, SC 29401-5799
Submitted July 15, 2004;
Revised November 22, 2004;
Accepted December 7, 2004
Monitoring Editor: Vivek Malhotra
Ceramide has been shown to cause anoikis, a subtype of apoptosis due to inadequate cell adhesion. However, the underlying mechanism is unclear. Herein, we report that D-e-C6-ceramide (D-e-Cer), via generating sphingosine, disrupts the Golgi complex (GC), which is associated with various cellular effects, including anoikis. Treatment of HeLa cells with D-e-Cer caused cell elongation, spreading inhibition, rounding, and detachment before apoptosis (anoikis). In D-e-Certreated cells, glycosylation of
1 integrin in the GC was inhibited, thus its associated integrin receptors failed to translocate to the cell surface. Ceramide treatment also inhibited the reorganization of both microtubule and F-actin cytoskeletons, focal adhesions, and filopodia. These cellular effects were preceded by fragmentation of the Golgi complex. In contrast, L-e-C6-ceramide (L-e-Cer), the enantiomer of D-e-Cer, failed to induce these cellular effects. Mass spectrometric analysis revealed that treatment HeLa cells with D-e-Cer but not L-e-Cer caused a >50-fold increase in the levels of sphingosine, a product of hydrolysis of ceramide. Treatment with D-e-sphingosine and its enantiomer, L-e-sphingosine, caused massive perinuclear vacuolization, Golgi fragmentation, and cell rounding. Together, these results suggest that sphingosine generated from hydrolysis of ceramide causes the GC disruption, leading to various cellular effects.
Address correspondence to: Cungui Mao (maoc{at}musc.edu).
This article has been cited by other articles:
![]() |
Y. H. Zeidan, R. W. Jenkins, and Y. A. Hannun Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway J. Cell Biol., April 21, 2008; 181(2): 335 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shen, M.-S. Hong, J. Moss, and M. Vaughan BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1 PNAS, January 23, 2007; 104(4): 1230 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moreau, F. Brandizzi, S. Hanton, L. Chatre, S. Melser, C. Hawes, and B. Satiat-Jeunemaitre The plant ER-Golgi interface: a highly structured and dynamic membrane complex J. Exp. Bot., January 1, 2007; 58(1): 49 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Fox, X. Han, S. Kelly, A. H. Merrill Jr., R. E. Martin, R. E. Anderson, T. W. Gardner, and M. Kester Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy Diabetes, December 1, 2006; 55(12): 3573 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Park, X. Shen, M. Samaraweera, and B. Y.J.T. Yue Studies of Optineurin, a Glaucoma Gene: Golgi Fragmentation and Cell Death from Overexpression of Wild-Type and Mutant Optineurin in Two Ocular Cell Types Am. J. Pathol., December 1, 2006; 169(6): 1976 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, J. Jin, W. Hu, W. Sun, J. Bielawski, Z. Szulc, T. Taha, L. M. Obeid, and C. Mao Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P FASEB J, September 1, 2006; 20(11): 1813 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Giussani, M. Maceyka, H. Le Stunff, A. Mikami, S. Lepine, E. Wang, S. Kelly, A. H. Merrill Jr., S. Milstien, and S. Spiegel Sphingosine-1-Phosphate Phosphohydrolase Regulates Endoplasmic Reticulum-to-Golgi Trafficking of Ceramide. Mol. Cell. Biol., July 1, 2006; 26(13): 5055 - 5069. [Abstract] [Full Text] [PDF] |
||||